ATE195427T1 - Pertussistoxin enthaltender influenzaimpfstoff - Google Patents

Pertussistoxin enthaltender influenzaimpfstoff

Info

Publication number: ATE195427T1
Authority: AT; Austria
Prior art keywords: amino acid; pertussistoxin; influenza vaccine; vaccine containing; substituted
Prior art date: 1995-01-16

Application number

AT96300197T

Other languages

English (en)

Inventor

Mark Roberts

Bearsden School

Original Assignee

Medeva Europ Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-01-16

Filing date

1996-01-09

Publication date

2000-09-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10768080&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE195427(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1996-01-09 Application filed by Medeva Europ Ltd filed Critical Medeva Europ Ltd

2000-09-15 Application granted granted Critical

2000-09-15 Publication of ATE195427T1 publication Critical patent/ATE195427T1/de

Links

108010081690 Pertussis Toxin Proteins 0.000 title abstract 3
229960003971 influenza vaccine Drugs 0.000 title 1
239000000427 antigen Substances 0.000 abstract 4
102000036639 antigens Human genes 0.000 abstract 4
108091007433 antigens Proteins 0.000 abstract 4
150000001413 amino acids Chemical class 0.000 abstract 3
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
102000005348 Neuraminidase Human genes 0.000 abstract 2
108010006232 Neuraminidase Proteins 0.000 abstract 2
206010022000 influenza Diseases 0.000 abstract 2
231100000252 nontoxic Toxicity 0.000 abstract 2
230000003000 nontoxic effect Effects 0.000 abstract 2
239000004475 Arginine Substances 0.000 abstract 1
239000004471 Glycine Substances 0.000 abstract 1
239000004472 Lysine Substances 0.000 abstract 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
239000002671 adjuvant Substances 0.000 abstract 1
125000000539 amino acid group Chemical group 0.000 abstract 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 1
230000002163 immunogen Effects 0.000 abstract 1
229960005486 vaccine Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Virology (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Immunology (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Mycology (AREA)
Microbiology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Pulmonology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

AT96300197T 1995-01-16 1996-01-09 Pertussistoxin enthaltender influenzaimpfstoff ATE195427T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9500788.6A GB9500788D0 (en)	1995-01-16	1995-01-16	Vaccine compositions

Publications (1)

Publication Number	Publication Date
ATE195427T1 true ATE195427T1 (de)	2000-09-15

Family

ID=10768080

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT96300197T ATE195427T1 (de)	1995-01-16	1996-01-09	Pertussistoxin enthaltender influenzaimpfstoff

Country Status (8)

Country	Link
EP (1)	EP0721782B1 (de)
AT (1)	ATE195427T1 (de)
DE (1)	DE69609739T2 (de)
DK (1)	DK0721782T3 (de)
ES (1)	ES2150631T3 (de)
GB (1)	GB9500788D0 (de)
GR (1)	GR3034773T3 (de)
PT (1)	PT721782E (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2164148C1 (ru) *	2000-08-09	2001-03-20	Петров Рэм Викторович	Вакцина против вируса гриппа и способ ее получения
PT1789084E (pt)	2004-09-09	2011-02-22	Novartis Vaccines & Diagnostic	Redução de riscos iatrogénicos pontenciais associados às vacinas contra a gripe
WO2006062637A2 (en)	2004-11-03	2006-06-15	Novartis Vaccines And Diagnostics Inc.	Influenza vaccination
AR077636A1 (es) *	2009-07-08	2011-09-14	Abbott Biologicals Bv	Vacuna viral y uso de la misma
US9657359B2 (en)	2010-09-07	2017-05-23	Novartis Ag	Generic assays for detection of mamalian reovirus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH03135923A (ja) *	1989-10-20	1991-06-10	Chemo Sero Therapeut Res Inst	百日咳毒素ｂオリゴマーの構成サブユニットを含有する経鼻接種ワクチン
IT1248735B (it) *	1990-06-21	1995-01-26	Sclavo Spa	Vaccini acellulari contro la pertosse
US20030072774A1 (en) *	1994-06-10	2003-04-17	Diane M. Gajewczyk	Proteinaceous adjuvants

1995
- 1995-01-16 GB GBGB9500788.6A patent/GB9500788D0/en active Pending
1996
- 1996-01-09 DK DK96300197T patent/DK0721782T3/da active
- 1996-01-09 EP EP96300197A patent/EP0721782B1/de not_active Expired - Lifetime
- 1996-01-09 PT PT96300197T patent/PT721782E/pt unknown
- 1996-01-09 DE DE69609739T patent/DE69609739T2/de not_active Expired - Fee Related
- 1996-01-09 ES ES96300197T patent/ES2150631T3/es not_active Expired - Lifetime
- 1996-01-09 AT AT96300197T patent/ATE195427T1/de not_active IP Right Cessation
2000
- 2000-11-07 GR GR20000402462T patent/GR3034773T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0721782A3 (de)	1997-04-16
DK0721782T3 (da)	2000-12-18
GB9500788D0 (en)	1995-03-08
EP0721782B1 (de)	2000-08-16
DE69609739D1 (de)	2000-09-21
DE69609739T2 (de)	2001-04-12
GR3034773T3 (en)	2001-02-28
EP0721782A2 (de)	1996-07-17
ES2150631T3 (es)	2000-12-01
PT721782E (pt)	2001-02-28

Legal Events

Date	Code	Title	Description
2001-03-15	UEP	Publication of translation of european patent specification
2009-10-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
MX9803290A (es)	1998-09-30	Composiciones de la vacuna influenza.
BR9906927A (pt)	2001-11-20	Proteìnas de neisseria meningitidis
AU3526995A (en)	1996-04-26	Vaccine compositions
FI974423A0 (fi)	1997-12-05	Immunologiset yhdistelmäkoostumukset ja menetelmät
FI913820A0 (fi)	1991-08-12	Traodlikt hemagglutinin fraon bordetella pertussis som baerarmolekyl foer konjugatvaccin.
IL102687A0 (en)	1993-01-14	Method for enhancing immunogenicity
ES2139879T3 (es)	2000-02-16	Adyuvante de la mucosa no toxico.
GB9209118D0 (en)	1992-06-10	Vaccine compositions
ES2074950A1 (es)	1995-09-16	Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda.
DK0745387T3 (da)	2005-02-21	Adjuvanser til virale vacciner
DK0764029T3 (da)	2002-10-21	Proteinadjuvanser
GB9401987D0 (en)	1994-03-30	Modified nucleic acid
AUPN901296A0 (en)	1996-04-26	Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis
DK0725653T3 (da)	2004-10-11	Vaccinepræparater
ATE121754T1 (de)	1995-05-15	Vakzine gegen bordetella.
DE69609739D1 (de)	2000-09-21	Pertussistoxin enthaltender Influenzaimpfstoff
FR2693655B1 (fr)	1994-10-14	Vaccin antirabique avirulent.
NL300336I1 (nl)	2008-04-01	Vaccin tegen de bof dat een jeryl-lynn virusstam bevat
CA2388054A1 (en)	2001-05-25	Compositions and methods for stimulating an immune response against infectious agents
ES2058570T3 (es)	1994-11-01	Procedimiento para la obtencion de una vacuna antirrabica no virulenta.
EP0563288A4 (en)	1994-08-24	Immunopotentiation of vaccines, particularly swine pleuropneumonia vaccines